DEVA:IST
Deva Holding AS
TRY 84.50
arrow_downward
-1.57%(-1.35) 1D
Oct 12, 10:09:42 AM GMT+3 · TRY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DEVA...
Open
TRY 85.85
High
TRY 86.25
Low
TRY 84.20
Mkt. cap
16.90B
Avg. vol.
660.43K
Volume
35.49K
52-wk high
TRY 109.30
52-wk low
TRY 57.50
EPS
-TRY 4.21
Shares outstanding
200.02M
No. of employees
3K
Open
TRY 85.85
High
TRY 86.25
Low
TRY 84.20
Mkt. cap
16.90B
Avg. vol.
660.43K
Volume
35.49K
52-wk high
TRY 109.30
52-wk low
TRY 57.50
EPS
-TRY 4.21
Shares outstanding
200.02M
No. of employees
3K
News stories
From web sources and news partners
TradingView
·
1 hour ago
SPX: S&P 500 Nears Record as Traders Gear Up for Earnings, Inflation Data
Benzinga
·
44 minutes ago
Dow Jumps Over 400 Points, Records Weekly Gain: Investor Sentiment Improves, Fear & Greed Index Moves yo
https://www.ababnews.com/
·
53 minutes ago
Barchart points out that the average return of the S&P 500 after midterm elections since 1950 is 17.2%
FXLeaders
·
8 hours ago
Dow Jones and Nasdaq Futures Start Higher Ahead of US Inflation Data
Profile
DEVA Holding A.Ş. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements.
A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas.
As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
About Deva Holding AS